You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

ZINC SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zinc Sulfate, and what generic alternatives are available?

Zinc Sulfate is a drug marketed by Abraxis Pharm, Am Regent, Apotex, Aspiro, Fresenius Kabi Usa, Gland, Nivagen Pharms Inc, Rk Pharma, Somerset Theraps Llc, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in ZINC SULFATE is zinc sulfate. There are thirty-eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc Sulfate

A generic version of ZINC SULFATE was approved as zinc sulfate by AM REGENT on July 18th, 2019.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ZINC SULFATE?
  • What are the global sales for ZINC SULFATE?
  • What is Average Wholesale Price for ZINC SULFATE?
Drug patent expirations by year for ZINC SULFATE
Drug Sales Revenue Trends for ZINC SULFATE

See drug sales revenues for ZINC SULFATE

Recent Clinical Trials for ZINC SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Queen Savang Vadhana Memorial Hospital, ThailandNA
Goldman, Butterwick, Fitzpatrick and GroffPHASE4
Hennepin Healthcare Research InstitutePHASE1

See all ZINC SULFATE clinical trials

Pharmacology for ZINC SULFATE
Medical Subject Heading (MeSH) Categories for ZINC SULFATE

US Patents and Regulatory Information for ZINC SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm ZINC SULFATE zinc sulfate INJECTABLE;INJECTION 019229-002 May 5, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Nivagen Pharms Inc ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 214597-003 Jul 5, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 217074-003 Aug 22, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aspiro ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 219585-001 May 1, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Am Regent ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 209377-001 Jul 18, 2019 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 216145-003 Dec 27, 2022 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rk Pharma ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 217624-002 Jun 10, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Zinc Sulfate

Last updated: January 15, 2026

Executive Summary

Zinc sulfate, an inorganic compound with extensive applications in medicine, agriculture, and industry, is experiencing evolving market dynamics driven by public health needs, regulatory shifts, and alternative therapeutics. This comprehensive analysis examines the current market size, growth prospects, competitive landscape, regulatory environment, and key financial indicators shaping zinc sulfate’s trajectory through 2030. Insights into supply chains, demand drivers, pricing trends, and technological innovations are detailed, providing critical intelligence for stakeholders seeking strategic positioning in this evolving market.


What Is Zinc Sulfate and Why Is It Market-Relevant?

Chemical Profile & Uses

Property Details
Chemical formula ZnSO₄·7H₂O (zinc sulfate heptahydrate)
Common forms Crystalline powder, granules, solutions
Primary uses Nutritional supplement, agricultural fertilizer, industrial catalyst, oral and topical medication, water treatment

Key Applications

Sector Major Uses Market Share (Estimate, 2022)
Pharmaceuticals Zinc deficiency tablets, lozenges, ointments ~40%
Agriculture Fertilizers, seed treatments ~30%
Industrial Water treatment, dyeing, rubber manufacturing ~15%
Others Animal feed, cosmetics ~15%

Market Size and Growth Trajectory

Global Market Valuation

Year Market Size (USD million) CAGR (2018–2022) Forecast (2023–2030)
2018 200 3.8%
2019 210
2020 215
2021 220
2022 225 4.5% CAGR projected
2030 (Forecast) ~330

Source: MarketWatch, 2023

Key Growth Drivers

  • Rising prevalence of zinc deficiency globally, especially in children and pregnant women (WHO, 2021)
  • Growth in organic farming requiring micronutrient supplements
  • Increased emphasis on immune-boosting health supplements amidst ongoing pandemics
  • Expansion of water treatment infrastructure in developing regions

Regional Market Dynamics

Region Market Share (2022) Growth Rate (2023–2030) Key Drivers
North America 25% 4.3% Nutritional supplements, regulatory policies
Europe 20% 4.2% Organic farming, environmental standards
Asia-Pacific 35% 5.0% Population growth, industrialization
Latin America & MEA 10% 5.2% Agricultural sector, infrastructure

Market Drivers and Challenges

Demand Drivers

  • Health and Nutrition: Zinc's role in immune function, wound healing, and enzyme activity sustains high demand for supplements.
  • Agricultural Necessity: Zinc deficiency in soil leads to lower crop yields, propelling fertilizer use.
  • Regulatory Supports: Approval of zinc-based therapeutics during COVID-19 increased acceptance.
  • Industrial Expansion: Handling of wastewater and dye manufacturing uses zinc sulfate as a precipitant or additive.

Challenges and Constraints

Factor Impact
Price Volatility Fluctuating raw material costs affect profit margins
Environmental Regulations Stricter discharge standards increase compliance costs
Supply Chain Disruptions Geopolitical tensions and pandemics impact raw material sourcing
Market Saturation Mature pharmaceutical markets see slow growth in certain segments

Competitive Landscape and Key Players

Major Manufacturers Estimated Market Share (2022) Geographical Presence Strategies
Norwegian Chemicals 15% Europe, Asia Vertical integration, R&D investments
Cachet Pharma Inc. 12% North America Product diversification, regulatory compliance
American Elements 10% Global Supply chain optimization, strategic alliances
Others 63% Global M&A activity, regional expansion

Recent M&A and Strategic Moves

  • Acquisition of regional chemical producers to enhance supply capacity.
  • Investment in environmentally friendly synthesis methods.
  • Collaborations with biotech firms for new zinc-based therapeutics.

Pricing Trends and Revenue Models

Parameter 2022 Average Price (USD/kg) Projected Price Range (2023–2030) Notes
Bulk industrial grade 2.50 2.00–3.00 Price sensitive to raw material costs
Pharmaceutical grade 20.00 18.00–25.00 Higher margins due to regulatory compliance
Fertilizer grade 1.80 1.50–2.20 Influenced by agricultural demand

Revenue Streams

  • Bulk wholesale sales to intermediaries
  • Direct-to-label manufacturing partnerships for pharmaceuticals
  • Licensing agreements for proprietary formulations

Regulatory Environment and Policy Impact

Key Regulations

Jurisdiction Regulatory Agency Standards and Policies Impact
USA FDA Monographs on zinc supplements, quality standards Market access requires compliance with Good Manufacturing Practices (GMP)
EU EMA & EFSA Nutritional and pharmaceutical approvals Stricter safety and efficacy evaluations increase time-to-market
China NMPA Manufacturing licenses, environmental regulations Growing domestic market with reduced import dependence
India CDSCO Quality standards for pharmaceuticals Large regional manufacturing hubs

Policy Trends

  • Emphasis on sustainable sourcing promotes eco-friendly production.
  • Incentives for agricultural micronutrient use in developing nations.
  • Increased focus on product transparency and safety labeling.

Technological Innovations and R&D

  • Development of zinc sulfate nanoparticles for targeted drug delivery.
  • Use of green synthesis methods reducing environmental impact.
  • Formulation enhancements for improved bioavailability.
  • Integration of zinc sulfate into combination nutraceuticals.

Financial and Investment Outlook

Projected Revenue Growth (2023–2030)

Year Estimated Revenue (USD million) Predicted CAGR Notes
2023 230 Post-pandemic recovery phase
2025 275 7.5% Emerging markets growth
2027 300 4.7% Market saturation in some segments
2030 330 4.5% Stabilization expected

Investment Opportunities

  • Expansion into emerging markets via joint ventures.
  • R&D funding in nanotechnology and eco-friendly synthesis.
  • Diversification into specialty zinc compounds.

Comparison with Alternative Zinc Compounds

Compound Advantages Limitations Market Position
Zinc Sulfate Cost-effective, high solubility, diverse applications Environmental impact from manufacturing Widely used for nutritional and agricultural uses
Zinc Oxide UV protection, antimicrobial Higher production costs Specialty applications, cosmetics
Zinc Chloride Industrial cleaning, textile processing Corrosive, limited use in health Niche industrial applications

FAQs

1. How does zinc sulfate compare in efficacy versus other zinc supplements?
Zinc sulfate provides high bioavailability in its pharmaceutical form, making it an effective supplement for zinc deficiency. However, formulations like zinc gluconate and zinc acetate are also prevalent, with bioavailability slightly varying based on molecular structure.

2. What are the emerging markets for zinc sulfate?
Asia-Pacific, especially India and China, exhibits the highest growth driven by agricultural needs and rising health awareness. Africa and Latin America show rapid adoption in water treatment and nutrition sectors.

3. What environmental considerations influence zinc sulfate manufacturing?
Manufacturing processes involve sulfuric acid use, energy consumption, and waste management. Regulatory trends push for greener synthesis routes that reduce carbon footprint and hazardous waste.

4. How are regulatory policies impacting market expansion in North America?
Stringent FDA standards necessitate rigorous quality controls, but also assure high product credibility, facilitating market expansion. Regulatory approval for new therapeutics can lead to accelerated uptake.

5. What technological advancements are influencing zinc sulfate’s market outlook?
Nanotechnology, bioavailability enhancement techniques, and sustainable production methods are shaping future commercial opportunities for zinc sulfate.


Key Takeaways

  • The global zinc sulfate market is poised for steady growth, with a projected CAGR of approximately 4.5% through 2030, reaching about USD 330 million.
  • Major demand drivers include rising zinc deficiencies, agricultural needs, and water treatment expansion in developing economies.
  • Market players focus on eco-friendly synthesis, technological innovation, and strategic M&A to enhance competitiveness.
  • Regulatory landscapes vary regionally but generally favor high-quality, sustainable products, influencing supply chain and cost strategies.
  • Investment opportunities lie in emerging markets, product diversification, and R&D in nanotechnology and green chemistry.

Stakeholders should monitor regulatory shifts, technological innovations, and regional growth patterns to optimize positioning in the zinc sulfate marketplace.


References

  1. World Health Organization (WHO). Zinc Deficiency. 2021.
  2. MarketWatch. "Zinc Sulfate Market Size, Share & Trends Analysis Report." 2023.
  3. European Food Safety Authority (EFSA). "Guidelines on micronutrient approvals." 2022.
  4. U.S. Food and Drug Administration (FDA). "Regulations on Dietary Supplements." 2022.
  5. Industry reports from MarketResearch.com, 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.